NEPTUNE Match Study
NCT04571658 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 375
Last updated 2026-05-06
Summary
NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matching with kidney patients and their physician investigators.
Conditions
- Nephrotic Syndrome in Children
- Focal Segmental Glomerulosclerosis
- Minimal Change Disease
- Minimal Change Nephrotic Syndrome
- Membranous Nephropathy
- FSGS
- MCD
- MCD - Minimal Change Disease
- Alport Syndrome
Interventions
- OTHER
-
Communication
The NEPTUNE Match study includes an interdisciplinary Communication Team that will translate findings from the Molecular Nephrology Board (MNB) to inform patients of the matching assessment with ongoing clinical trials. This team has considerable experience with conveying complex biomedical research information to patients and families and includes experts in precision nephrology, nephrology patient \[adult and pediatric\] communication, and health education.
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH - lead OTHER
Principal Investigators
-
Matthias Kretzler, MD · University of Michigan
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Year
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-02
- Primary Completion
- 2029-12-30
- Completion
- 2029-12-30
Countries
- United States
Study Locations
More Related Trials
-
An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
NCT05809531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
NCT00987389 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients
NCT06099236 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
NCT06962800 ·Status: RECRUITING ·Phase: PHASE3
-
Therapeutic Effect of Immunoadsorption for Patients With Lipoprotein Glomerulopathy
NCT00302510 ·Status: COMPLETED ·Phase: NA
-
Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
NCT00001764 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
NCT02981212 ·Status: UNKNOWN ·Phase: PHASE4
-
Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study
NCT01185197 ·Status: COMPLETED ·Phase: PHASE4
-
Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
NCT00001473 ·Status: COMPLETED
-
Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)
NCT00657059 ·Status: COMPLETED ·Phase: PHASE3
-
Steroids and Methotrexate to Treat Systemic Vasculitis
NCT00001256 ·Status: COMPLETED ·Phase: PHASE2
-
Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy
NCT03170323 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy
NCT01451710 ·Status: COMPLETED ·Phase: NA
-
Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
NCT00530075 ·Status: COMPLETED ·Phase: PHASE2
-
Contrast-Enhanced US of Spleen, Liver and Kidney
NCT00190281 ·Status: UNKNOWN
-
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
NCT00307671 ·Status: COMPLETED ·Phase: PHASE4
-
A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.
NCT02160132 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes
NCT00004567 ·Status: COMPLETED ·Phase: PHASE2
-
The Clinical Efficacy of DFPP in Patients With AAGN
NCT02294344 ·Status: TERMINATED ·Phase: NA
-
The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children
NCT02532790 ·Status: UNKNOWN ·Phase: PHASE2
-
Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy
NCT00301600 ·Status: COMPLETED ·Phase: NA
-
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
NCT06614998 ·Status: RECRUITING
-
Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis
NCT04318600 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome
NCT01197040 ·Status: COMPLETED ·Phase: PHASE3
-
MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis
NCT00301652 ·Status: COMPLETED ·Phase: NA